Skip to NavigationSkip to content

Top Ten most popular articles on Pharmafile.com this week

Published on 24/07/20 at 10:21am

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it, while health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.

In non-coronavirus related news, the FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.

1. Israeli doctor tests positive for coronavirus 3 months after recovering

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it.

2. UK secures early access to 90 million doses of coronavirus vaccines

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

3. Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising data on the interferon beta-based therapy, known as SNG001, in the treatment of patients hospitalised with the disease.

4. Face shields did not protect people from a COVID-19 outbreak in Switzerland but masks did, according to health officials

Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.

5. Mylan launches generic version of Gilead's remdesivir for COVID-19 patients in India

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with COVID-19 under the brand name Desrem, it has emerged.

6. Hydroxychloroquine proves ineffective against COVID-19 in newest trial

The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients.

7. Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait.

8. FDA sets out guidelines on cannabis derived drugs

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.

 

9. Study launched to assess if asthma treatment ciclesonide can treat COVID-19Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective in treating the coronavirus.

9. Study launched to assess if asthma treatment ciclesonide can treat COVID-19

Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective in treating the coronavirus.

10. British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee

There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according to a cross-party group of MPs.

 

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches